La Dismorfología como Herramienta para un Diagnóstico Temprano de la Anemia de Fanconi; Dysmorphology as a Tool for Earlier Diagnosis of Fanconi Anemia

Moisés Ó Fiesco-Roa, Paulina G Gómez-Moreno, Rubí M Espinosa-Curiel, Alfredo Rodríguez, Sara Frías Vázquez


La anemia de Fanconi es un síndrome de inestabilidad cromosómica que cursa con falla medular, alteraciones dismorfológicas y predisposición a cáncer. Las manifestaciones de esta enfermedad incluyen anomalías del desarrollo que son parte de los acrónimos VACTERL-H y PHENOS. Estas alteraciones pueden detectarse a edades tempranas, incluso antes del inicio de las manifestaciones hemato-oncológicas. Aquí describimos cómo la búsqueda y evaluación de estas manifestaciones puede conducir a un diagnóstico temprano de la anemia de Fanconi.


Fanconi anemia is a chromosome instability syndrome associated with bone marrow failure, physical abnormalities, and cancer predisposition. The Fanconi anemia phenotype includes several morphological anomalies that are part of the VACTERL-H and PHENOS acronyms. These physical alterations can be detected at an early age, even before the onset of hemato-oncological manifestations. Here we describe how to look for and evaluate these manifestations, leading to an early diagnosis of Fanconi anemia.



Texto completo:



Smith DW. Dysmorphology (teratology). The Journal of Pediatrics. 1966;69(6). doi:10.1016/S0022-3476(66)80311-6

Hennekam RC, Biesecker LG, Allanson JE, et al. Elements of morphology: General terms for congenital anomalies. American Journal of Medical Genetics Part A. 2013;161(11). doi:10.1002/ajmg.a.36249

del Castillo Ruiz V, Uranga Hernández RD, Zafra de la Rosa G. Genética Clínica. 2nd ed. Manual Moderno; 2019

García-de-Teresa B, Rodríguez A, Frias S. Chromosome Instability in Fanconi Anemia: From Breaks to Phenotypic Consequences. Genes. 2020;11(12). doi:10.3390/genes11121528

ORPHANET. Fanconi Anemia Orphanet.

Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Reviews. 2010;24(3):101-122. doi:10.1016/j.blre.2010.03.002

Risitano AM, Marotta S, Calzone R, Grimaldi F, Zatterale A. Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned. Haematologica. 2016;101(3):319-327. doi:10.3324/haematol.2015.133520

Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in the national cancer institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2018;103(1):30-39. doi:10.3324/haematol.2017.178111

Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer. 2003;97(2):425-440. doi:10.1002/cncr.11046

Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101(3):822-826. doi:10.1182/blood-2002-05-1498

Fiesco-Roa MO, Giri N, McReynolds LJ, Best AF, Alter BP. Genotype-phenotype associations in Fanconi anemia: A literature review. Blood Reviews. 2019;37. doi:10.1016/j.blre.2019.100589

Knies K, Inano S, Ramírez MJ, et al. Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia. Journal of Clinical Investigation. 2017;127(8). doi:10.1172/JCI92069

Rodríguez A, D’Andrea A. Fanconi anemia pathway. Current Biology. 2017;27(18):R986-R988. doi:10.1016/j.cub.2017.07.043

Alter BP, Giri N. Thinking of VACTERL-H? Rule out Fanconi Anemia according to PHENOS. American Journal of Medical Genetics, Part A. 2016;170(6):1520-1524. doi:10.1002/ajmg.a.37637

Ruggiero JL, Dodds M, Freese R, et al. Cutaneous findings in Fanconi anemia. Journal of the American Academy of Dermatology. Published online 2021. doi:10.1016/j.jaad.2020.08.047

Stivaros SM, Alston R, Wright NB, et al. Central nervous system abnormalities in Fanconi anaemia: patterns and frequency on magnetic resonance imaging. The British Journal of Radiology. 2015;88(1056). doi:10.1259/bjr.20150088

D’Souza F, Usha MK, Rao S. Fanconi’s Anemia in Monozygotic Twins. Vol 74.; 2007.

Stevens H, Chyn Chua C, Wallis M, Hew S, Grigg A. Fanconi anemia in 55‐year‐old identical twins first presenting as fatal post‐chemotherapy pancytopenia. American Journal of Hematology. 2016;91(12). doi:10.1002/ajh.24488

Temtamy SA, Miller JD. Extending the scope of the VATER association: Definition of the VATER syndrome. The Journal of Pediatrics. 1974;85(3). doi:10.1016/S0022-3476(74)80113-7

Nora AH, Nora JJ. A Syndrome of Multiple Congenital Anomalies Associated With Teratogenic Exposure. Archives of Environmental Health: An International Journal. 1975;30(1). doi:10.1080/00039896.1975.10666626

Genuardi M, Chiurazzi P, Capelli A, Neri G. X-linked VACTERL with hydrocephalus: the VACTERL-H syndrome. Birth defects original article series. 1993;29(1)

Quan L, Smith DW. The VATER association. The Journal of Pediatrics. 1973;82(1). doi:10.1016/S0022-3476(73)80024-1

Solomon BD, Bear KA, Kimonis V, et al. Clinical geneticists’ views of VACTERL/VATER association. American Journal of Medical Genetics Part A. 2012;158A(12). doi:10.1002/ajmg.a.35638

Solomon BD. The etiology of VACTERL association: Current knowledge and hypotheses. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2018;178(4). doi:10.1002/ajmg.c.31664

Porteous MEM, Cross I, Burn J. VACTERL with hydrocephalus: One end of the Fanconi anemia spectrum of anomalies? American Journal of Medical Genetics. 1992;43(6). doi:10.1002/ajmg.1320430624

Wang H, Hunter AGW, Clifford B, McLaughlin M, Thompson D. VACTERL with hydrocephalus: Spontaneous chromosome breakage and rearrangement in a family showing apparent sex-linked recessive inheritance. American Journal of Medical Genetics. 1993;47(1). doi:10.1002/ajmg.1320470124

Alter BP, Rosenberg PS. VACTERL-H association and fanconi anemia. Molecular Syndromology. 2013;4(1-2):87-93. doi:10.1159/000346035

Faivre L, Portnoï MF, Pals G, et al. Should chromosome breakage studies be performed in patients with VACTERL association? American Journal of Medical Genetics. 2005;137 A(1):55-58. doi:10.1002/ajmg.a.30853

Esmer C, Sánchez S, Ramos S, Molina B, Frias S, Carnevale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. American Journal of Medical Genetics Part A. 2004;124A(1). doi:10.1002/ajmg.a.20327

Fiesco Roa M, Monsivais Orozco A, Rodriguez A, Frías S, Garcia-de Teresa B. Síndromes de falla medular hereditarios: etiología, fisiopatología, diagnóstico y tratamiento. Acta Pediátrica de México. 2021;42(4):192-207

Sevilla-Montoya R, Aguinaga M, Martínez A, et al. Heterogeneous Diagnoses Underlying Radial Ray Anomalies. The Indian Journal of Pediatrics. 2017;84(3). doi:10.1007/s12098-016-2270-4

García-De Teresa B, Hernández-Gómez M, Frías S. DNA Damage as a Driver for Growth Delay: Chromosome Instability Syndromes with Intrauterine Growth Retardation. BioMed Research International. 2017;2017. doi:10.1155/2017/8193892

Auerbach AD. Fanconi anemia and its diagnosis. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2009;668(1-2). doi:10.1016/j.mrfmmm.2009.01.013

Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Experimental hematology. 1993;21(6)

Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73(2)

Frías S, Carnevale A, del Castillo V. [Use of a test exposing lymphocytes to mitomycin C in the diagnosis of Fanconi’s anemia]. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 36(3)

Sasaki MS, Tonomura A. A high susceptibility of Fanconi’s anemia to chromosome breakage by DNA cross-linking agents. Cancer research. 1973;33(8)

Schroeder TM, Anschütz F, Knopp A. Spontane Chromosomenaberrationen bei familiärer Panmyelopathie. Human Genetics. 1964;1(2). doi:10.1007/BF00389636

Chandrasekharappa SC, Lach FP, Kimble DC, et al. Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia. Blood. 2013;121(22). doi:10.1182/blood-2012-12-474585


Enlaces refback

  • No hay ningún enlace refback.